PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients ...

Incyte has entered into a $750m definitive agreement to acquire Escient Pharmaceuticals and its pipeline of small molecule ...

Fox&Cat relaunches today with its new people-first, senior consultant operating model and bespoke planning framework, ADAPT ...

If you’ve worked in pharma marketing, you’ll know how hard it can be of late. You’ll spend a load of budget on what looks and ...

PME spoke to Marci English, Vice President and Head of BioPharma Development, Astellas, about the importance of new ...

Affecting up to one in three people globally in their lifetimes with long-lasting pain and other complications, shingles or ...

Takeda and Kumquat Biosciences have entered into a collaboration agreement worth over $1.2bn to advance an oral ...

We are a highly experienced group of consultants who collaborate to deliver a wide range of medical communication services. We create bespoke teams of experts to deliver intelligent communication ...

Researchers from the Institute of Cancer Research (ICR) have discovered a new way to convert inhibitor-style targeted cancer ...

Sanofi has shared promising results from a mid-stage study of its investigational anti-CD40L antibody, frexalimab, in ...

Roche has announced positive phase 3 results for its ten-minute subcutaneous (SC) Ocrevus (ocrelizumab) injection in patients ...

A new UK-wide report commissioned by Bristol Myers Squibb (BMS) and Shine Cancer Support has revealed disparities in cancer ...